Close X
Get more out of
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.

Click here if you're interested
Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!


It's better than the lottery, folks: how to blow the whistle on a dru
About the author: 

Our man of the week is Douglas Durand, who's just walked away with $46

Our man of the week is Douglas Durand, who's just walked away with $46.5 (lb29.7m) after he blew the whistle on UK drugs giant AstraZeneca over one of their prostate cancer drugs.

The company has been found guilty in the United States of a felony charge of health fraud, and has agreed to pay $355m to settle criminal and civil accusations that it illegally marketed the drug Zoladex.

The company had given illegal financial inducements to up to 400 doctors to try the new drug on their patients. The inducements included free samples of Zoladex, which the physicians then billed to Medicare, financial grants, and free travel and entertainment.

It is the second largest fine for health fraud in the United States. The largest was against TAP Pharmaceutical Products, which coughed up $875m in 2001 following similar charges.

AstraZeneca and TAP were both aggressively marketing a new prostate drug (TAP's was Lupron), and Mr Durand, a former vice president at TAP, blew the whistle on both companies. Under American law, the whistle-blower is entitled to a share of the fine - and Mr Durand really cleaned up. He receives $46.5m for the AstraZeneca case, and $77m for the TAP discovery.

There are plenty more similar cases in the wings. AstraZeneca is also being investigated over the sale of its anti-ulcer drug Prilosec and its heartburn treatment Nexium.

Speaking to the press after the AstraZeneca case, Richard Andrews, first assistant United States attorney for the District of Delaware, said: 'We want doctors to prescribe what is best for their patients and not what is best for the doctor's bank account.'

This is an outrageous statement, and one that displays the man's ignorance. Such a view would turn on its head all the marketing efforts of every pharmaceutical company.

Nonetheless, you might wonder how you can join in this smorgasbord of whistle-blowing. After all, Mr Durand was privy to insider knowledge, you might protest, but we say to you: you're missing the point - because EVERY drug company is doing it!

Now, you need to do yourself a favour (and here we must make a blatant advertisement). Instead of wasting your money on the lottery this week, save your pennies and buy a copy of our book, The Secrets of the Drugs Industry. At just lb13.75 including post and packing (within the UK), it gives the lowdown on all their dirty tricks. Don't forget - Attorney Richard Andrews is waiting to hear from you, chequebook at the ready.

To order your copy of The Secrets of the Drugs Industry, click here:

You may also be interested in...

Latest Tweet


Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2017 WDDTY Publishing Ltd.
All Rights Reserved